Case Report
BibTex RIS Cite

Regression of chronic subdural hematoma under antiplatelet treatment: An unusual case

Year 2024, Volume: 41 Issue: 1, 221 - 223, 29.03.2024

Abstract

The surgical evacuation is considered as the first choice of treatment for symptomatic chronic subdural hematoma. Since anticoagulation is considered a risk factor and any ongoing anticoagulation treatment is ceased once the diagnosis is confirmed, the data regarding the course of these cases under ongoing anticoagulant treatment remains extremely limited. A 73-year-old female was given antiplatelet treatment for ischemic stroke for right hemiparesis and dysarthria despite an existing, but unrecognized chronic subdural hematoma. The hematoma was discovered after 4 weeks following antiplatelet treatment, but in a smaller volume. As routine practice antipaletelet treatment was ceased and the hematoma completely resolved within 2 weeks. This case demonstrates that some patients with chronic subdural hematoma for whom continuation of anticoagulation is essential, can be observed closely if hematoma volume is small and no midline shift is present since spontaneous resolution may occur.

References

  • Yang W, Huang J. Chronic Subdural Hematoma: Epidemiology and Natural History. Neurosurg Clin N Am. 2017; 28(2): 205-210.
  • Soleman J, Nocera F, Mariani L. The conservative and pharmacological management of chronic subdural haematoma. Swiss Med Wkly. 2017; 147: w14398.
  • Junior MGP, Pessoa BL, Landeiro JA, de Abreu Macedo PH, Leite MAA. Spontaneous resolution of chronic subdural hematoma: Does only the size matter? Surg Neurol Int. 2019; 10: 194.
  • Kim HC, Ko JH, Yoo DS, Lee SK. Spontaneous Resolution of Chronic Subdural Hematoma : Close Observation as a Treatment Strategy. J Korean Neurosurg Soc. 2016; 59(6): 628-636.
  • Tiwari AR, Maheshwari S, Balasubramaniam S, Devendra T, Savant H. Spontaneous Resolution of Non Traumatic Chronic Subdural Haematoma Despite Continued Antiplatelet Therapy: A Case Report. J Clin Diagn Res. 2015; 9(6): Pd01-2.
  • Neth BJ, Ighodaro ET, Brinjikji W, Cloft H, Scharf EL. Management of Chronic Subdural Hematoma in Patients Requiring Therapeutic Anticoagulation. Neurologist. 2022; 27(4): 211-213.
  • Yang S, Zhang X, Jin Y. Spontaneous resolution of nontraumatic chronic subdural hematoma associated with anti-aggregation therapy. J Craniofac Surg. 2014; 25(4): e363-5
Year 2024, Volume: 41 Issue: 1, 221 - 223, 29.03.2024

Abstract

References

  • Yang W, Huang J. Chronic Subdural Hematoma: Epidemiology and Natural History. Neurosurg Clin N Am. 2017; 28(2): 205-210.
  • Soleman J, Nocera F, Mariani L. The conservative and pharmacological management of chronic subdural haematoma. Swiss Med Wkly. 2017; 147: w14398.
  • Junior MGP, Pessoa BL, Landeiro JA, de Abreu Macedo PH, Leite MAA. Spontaneous resolution of chronic subdural hematoma: Does only the size matter? Surg Neurol Int. 2019; 10: 194.
  • Kim HC, Ko JH, Yoo DS, Lee SK. Spontaneous Resolution of Chronic Subdural Hematoma : Close Observation as a Treatment Strategy. J Korean Neurosurg Soc. 2016; 59(6): 628-636.
  • Tiwari AR, Maheshwari S, Balasubramaniam S, Devendra T, Savant H. Spontaneous Resolution of Non Traumatic Chronic Subdural Haematoma Despite Continued Antiplatelet Therapy: A Case Report. J Clin Diagn Res. 2015; 9(6): Pd01-2.
  • Neth BJ, Ighodaro ET, Brinjikji W, Cloft H, Scharf EL. Management of Chronic Subdural Hematoma in Patients Requiring Therapeutic Anticoagulation. Neurologist. 2022; 27(4): 211-213.
  • Yang S, Zhang X, Jin Y. Spontaneous resolution of nontraumatic chronic subdural hematoma associated with anti-aggregation therapy. J Craniofac Surg. 2014; 25(4): e363-5
There are 7 citations in total.

Details

Primary Language English
Subjects Brain and Nerve Surgery (Neurosurgery)
Journal Section Case Report
Authors

Sinan Bahadır 0000-0002-1037-5645

Faruk Tonga 0000-0001-7133-8613

Publication Date March 29, 2024
Submission Date December 3, 2023
Acceptance Date December 20, 2023
Published in Issue Year 2024 Volume: 41 Issue: 1

Cite

APA Bahadır, S., & Tonga, F. (2024). Regression of chronic subdural hematoma under antiplatelet treatment: An unusual case. Journal of Experimental and Clinical Medicine, 41(1), 221-223.
AMA Bahadır S, Tonga F. Regression of chronic subdural hematoma under antiplatelet treatment: An unusual case. J. Exp. Clin. Med. March 2024;41(1):221-223.
Chicago Bahadır, Sinan, and Faruk Tonga. “Regression of Chronic Subdural Hematoma under Antiplatelet Treatment: An Unusual Case”. Journal of Experimental and Clinical Medicine 41, no. 1 (March 2024): 221-23.
EndNote Bahadır S, Tonga F (March 1, 2024) Regression of chronic subdural hematoma under antiplatelet treatment: An unusual case. Journal of Experimental and Clinical Medicine 41 1 221–223.
IEEE S. Bahadır and F. Tonga, “Regression of chronic subdural hematoma under antiplatelet treatment: An unusual case”, J. Exp. Clin. Med., vol. 41, no. 1, pp. 221–223, 2024.
ISNAD Bahadır, Sinan - Tonga, Faruk. “Regression of Chronic Subdural Hematoma under Antiplatelet Treatment: An Unusual Case”. Journal of Experimental and Clinical Medicine 41/1 (March 2024), 221-223.
JAMA Bahadır S, Tonga F. Regression of chronic subdural hematoma under antiplatelet treatment: An unusual case. J. Exp. Clin. Med. 2024;41:221–223.
MLA Bahadır, Sinan and Faruk Tonga. “Regression of Chronic Subdural Hematoma under Antiplatelet Treatment: An Unusual Case”. Journal of Experimental and Clinical Medicine, vol. 41, no. 1, 2024, pp. 221-3.
Vancouver Bahadır S, Tonga F. Regression of chronic subdural hematoma under antiplatelet treatment: An unusual case. J. Exp. Clin. Med. 2024;41(1):221-3.